Geroscience

Papers
(The H4-Index of Geroscience is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes344
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss201
Effect of rapamycin on aging and age-related diseases—past and future111
The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis108
Severe COVID-19 and aging: are monocytes the key?103
COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches99
Single-cell RNA sequencing identifies senescent cerebromicrovascular endothelial cells in the aged mouse brain97
Increase in blood–brain barrier leakage in healthy, older adults94
The gut microbiome–derived metabolite trimethylamine N-oxide modulates neuroinflammation and cognitive function with aging82
Regulation of senescence traits by MAPKs76
Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary66
Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis65
Retinal biomarkers for Alzheimer’s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis63
Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries61
Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans58
A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge55
Does SARS-CoV-2 infection cause chronic neurological complications?49
Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition48
Intermittent fasting: from calories to time restriction46
Heterochronic parabiosis regulates the extent of cellular senescence in multiple tissues46
Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load45
Regulation of TDP-43 phosphorylation in aging and disease41
Nursing homes and the elderly regarding the COVID-19 pandemic: situation report from Hungary41
Decline in endothelial function across the menopause transition in healthy women is related to decreased estradiol and increased oxidative stress41
Imaging the role of blood–brain barrier disruption in normal cognitive ageing40
Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice38
Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction38
Aging alters acetylation status in skeletal and cardiac muscles37
Aging exacerbates impairments of cerebral blood flow autoregulation and cognition in diabetic rats36
Companion animals likely do not spread COVID-19 but may get infected themselves36
Plasma dilution improves cognition and attenuates neuroinflammation in old mice36
Mitochondrial-derived peptides in aging and age-related diseases35
Targeting mitochondrial dysfunction with small molecules in intervertebral disc aging and degeneration35
Identification of biomarkers for physical frailty and sarcopenia through a new multi-marker approach: results from the BIOSPHERE study35
Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice: transcriptional footprint of mitochondrial protection, attenuation of oxidative stress, and re35
0.030349016189575